The present disclosure relates to phenyl urea derivatives useful for the treatment of inflammatory diseases, pharmaceutical compositions containing them and their use as modulators of the N-formyl peptide receptor (FPR), including FPRl and FPR2, or as selective agonists of the FPRl receptor.
本公开涉及苯基
脲衍
生物,其可用于治疗炎症性疾病,包含它们的制药组合物以及它们作为N-甲基肽受体(FPR)的调节剂,包括FPRl和FPR2,或作为FPRl受体的选择性激动剂的用途。